A substance being studied in the treatment of some types of cancer. Canertinib dihydrochloride blocks the action of proteins called epidermal growth factor receptors, and may cause cancer cells to die. It is a type of tyrosine kinase inhibitor. Also called CI-1033.
( can-ER-tih-nib dy-HY-droh-KLOR-ide )
Source: NCI Dictionary of Cancer Terms
Search the Glossary of Medical Terms
Newsletter
Sign up for the QuackTrack.org newsletter below!